Metal-Induced Fatty Acid Particle Formation Resulting from Hydrolytic Polysorbate Degradation

J Pharm Sci. 2022 Mar;111(3):743-751. doi: 10.1016/j.xphs.2021.09.044. Epub 2021 Oct 1.

Abstract

The occurrence of visible particles over the shelf-life of biopharmaceuticals is considered a potential safety risk for parenteral administration. In many cases, particle formation resulted from the accumulation of fatty acids released by the enzymatic hydrolysis of the polysorbate surfactant by co-purified host cell proteins. However, particle formation can occur before the accumulated fatty acids exceed their expected solubility limit. This early onset of particle formation is driven by nucleation phenomena e.g. the presence of metal cations that promote the formation and growth of fatty acid particles. To further characterize and understand this phenomenon, we assessed the potential of different metal cations to induce fatty acid particle formation using a dynamic light scattering assay. We demonstrated that the presence of trace amounts of multivalent cations, in particular trivalent cations such as aluminum and iron, may act as nucleation seed in the process of particle formation. Finally, we developed a mitigation strategy for metal-induced fatty acid particles that deploys a chelator to reduce the risk of particle formation in biopharmaceutical formulations.

Keywords: Degradation; Dynamic light scattering; Fatty acids; Hydrolysis; Metal impurities; Nucleation; Polysorbate; Surfactant; Visible particles.

MeSH terms

  • Biological Products*
  • Chemistry, Pharmaceutical
  • Fatty Acids
  • Hydrolysis
  • Polysorbates*
  • Surface-Active Agents

Substances

  • Biological Products
  • Fatty Acids
  • Polysorbates
  • Surface-Active Agents